Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

the-shenzhen-expressway-corporation-limited-(hkg:548)-analyst-just-cut-their-revenue-forecast-by-15%

The Shenzhen Expressway Corporation Limited (HKG:548) Analyst Just Cut Their Revenue Forecast By 15%

Mar 31, 2026

The latest analyst coverage could presage a bad day for Shenzhen Expressway Corporation Limited (HKG:548), with the covering…

Read more
fwona:-new-analyst-coverage-and-rating-by-citizens

FWONA: New Analyst Coverage and Rating by Citizens

Mar 30, 2026

Key Takeaways Citizens initiates coverage on Liberty Media (FWONA) with a “Market Outperform” rating. Price target set at…

Read more
morgan-stanley-initiates-waystar-stock-coverage-with-equalweight-rating

Morgan Stanley initiates Waystar stock coverage with Equalweight rating

Mar 30, 2026

Morgan Stanley initiates Waystar stock coverage with Equalweight rating

Read more
this-live-nation-entertainment-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-monday-–-fubotv-(nyse:fubo),-opus-genetics-(nasdaq:ird)

This Live Nation Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday – FuboTV (NYSE:FUBO), Opus Genetics (NASDAQ:IRD)

Mar 30, 2026

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
analyst-sets-palantir-stock-price-target-amid-white-house’s-golden-dome-plan

Analyst sets Palantir stock price target amid White House’s Golden Dome plan

Mar 30, 2026

Rosenblatt reiterated a “Buy” rating with a $200 price target on Palantir (NASDAQ: PLTR) on Wednesday, March 25,…

Read more
first-analyst-coverage-for-this-stock-riding-on-construction,-data-centre-tailwinds

First Analyst Coverage for This Stock Riding on Construction, Data Centre Tailwinds

Mar 30, 2026

Details 30 March 2026 • Since its founding in 1980, Tai Sin Electric has built a formidable moat in…

Read more
will-board-exit-and-new-coverage-reframe-globus-medical’s-governance-and-growth-narrative-(gmed)?

Will Board Exit and New Coverage Reframe Globus Medical’s Governance and Growth Narrative (GMED)?

Mar 30, 2026

Globus Medical, Inc. recently announced that Director John A. DeFord, PhD, resigned from its Board of Directors with…

Read more
dell-technologies-analyst-ratings-and-price-targets-|-nyse:dell

Dell Technologies Analyst Ratings and Price Targets | NYSE:DELL

Mar 29, 2026

España Italia 대한민국 日本 Français Benzinga Edge Benzinga Research Benzinga Pro Get Benzinga Pro Data & APIs Events…

Read more
couloir-capital-is-pleased-to-announce-that-it-has-updated-its-research-coverage-on-abcourt-mines

Couloir Capital Is Pleased to Announce That It Has Updated Its Research Coverage on Abcourt Mines

Mar 28, 2026

Vancouver, British Columbia–(Newsfile Corp. – March 25, 2026) – Couloir Capital is pleased to announce that it has…

Read more

Daily Stock Ratings | Stock Price Targets

Mar 28, 2026

Daily analyst ratings and price targets for US stocks . See today’s stock ratings by financial analysts around…

Read more
argan-earnings-are-imminent;-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call

Argan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 28, 2026

Argan, Inc. (NYSE:AGX) will release earnings for its fourth quarter after the closing bell on Thursday, March 26.…

Read more
biotech-price-target-raised-on-strong-fshd-and-dm1-sirna-data

Biotech Price Target Raised on Strong FSHD and DM1 siRNA Data

Mar 28, 2026

Source: Dr. Yun Zhong (3/27/26) Wedbush Securities raised its price target on Sarepta Therapeutics Inc. (SRPT:NASDAQ), following promising…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 12
  6. 13
  7. 14
  8. 15
  9. 16
  10. 17
  11. 18
  12. ...
  13. 394
  14. »

Posts pagination

Newer posts Page 1 … Page 15 … Page 394 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.